December 12, 2019
WELLESLEY, Mass., Dec. 12, 2019– Growth in the bioinformatics market has been driven by the uptake of Next Generation Sequencing (NGS) sequencing and cloud computing solutions. Companies are looking for suppliers that can offer total integration of the data infrastructure, according to a report by BCC Research, "Bioinformatics: Markets and Technologies.”
The market expects to see a compound annual growth rate (CAGR) of 21.7% through 2023, when it could be worth $20 billion.
“Bioinformatics plays an essential role in the drug development process, from the concept of designing drugs to the analysis of clinical data to support drug files,” according to BCC Research analyst Vijay Laxmi. “High-throughput technologies are now being adopted and used to improve the efficiency and to optimize drug selection and clinical evaluation.”
Mobile and Wearable Technology to Transform Healthcare Services Thanks to Bioinformatics
Mobile and wearable technology is expected to transform healthcare services through telehealth, remote patient monitoring and analytics. The use of clinical mobility, which includes the use of mobile devices such as tablets, mobile computers and wearable sensors by healthcare professionals, can expand the use of mobile devices in healthcare to elevate patient care and to assure that healthcare has more a personalized approach. This is expected to result in an explosion of biological data supplementing the market of bioinformatics.
Editors/reporters requesting analyst interviews should contact Sarah Greenberg at email@example.com.
Bioinformatics: Technologies and Global Markets( BIO051E )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.